NDC 45802-499 – Alogliptin and Pioglitazone
Alogliptin Benzoate 25 mg/1; Pioglitazone Hydrochloride 45 mg/1 · Tablet, Film Coated · Oral
Product NDC45802-499
Product details
- Brand name
- Alogliptin and Pioglitazone
- Generic name
- Alogliptin Benzoate and Pioglitazone hydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA022426
- Marketed since
- April 8, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Dipeptidyl Peptidase 4 Inhibitor; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione
Active ingredients
- Alogliptin Benzoate 25 mg/1
- Pioglitazone Hydrochloride 45 mg/1
Uses, dosage, side effects and warnings for Alogliptin and Pioglitazone →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 45802-499-65 | 30 TABLET, FILM COATED in 1 BOTTLE (45802-499-65) | Apr 8, 2016 |
Other Alogliptin and Pioglitazone products
- 45802-260 Alogliptin Benzoate 12.5 mg/1; Pioglitazone Hydrochloride 30 mg/1 · Tablet, Film Coated · Padagis Israel Pharmaceuticals Ltd
- 45802-351 Alogliptin Benzoate 25 mg/1; Pioglitazone Hydrochloride 15 mg/1 · Tablet, Film Coated · Padagis Israel Pharmaceuticals Ltd
- 45802-402 Alogliptin Benzoate 25 mg/1; Pioglitazone Hydrochloride 30 mg/1 · Tablet, Film Coated · Padagis Israel Pharmaceuticals Ltd